Atlas Venture
Anthony Slavin is an experienced pharmaceutical executive currently serving as an Entrepreneur in Residence at Atlas Venture since May 2024. Prior to this role, Anthony was Vice President at Kymera Therapeutics from May 2019 to May 2024. Between May 2014 and May 2019, Anthony held the position of Senior Director, and earlier, Director of Immunology Pharmacology and Exploratory Toxicology at AbbVie. Anthony's career also includes a tenure as Director of Immunology & Inflammation at Boehringer Ingelheim Pharmaceuticals from June 2009 to May 2014, and as Group Leader at the Genomics Institute of the Novartis Research Foundation from March 2008 to June 2009.
This person is not in any teams
This person is not in any offices